image stringlengths 20 66 | question stringclasses 16
values | answer stringlengths 3 10.7k |
|---|---|---|
PMC9414032_F1_385448.jpg | What is the central feature of this picture? | Brain imaging. (A–E) Axial diffusion-weighted of brain MRI on Diffusion-Weighted Imaging shows water restriction in the left occipital lobes, related to the first stroke-like episode, and (F–J) in the right temporal occipital lobe, related to the second stroke-like episode. (K,L) Brain Magnetic Resonance Spectroscopy s... |
PMC9414032_F1_385444.jpg | What is the principal component of this image? | Brain imaging. (A–E) Axial diffusion-weighted of brain MRI on Diffusion-Weighted Imaging shows water restriction in the left occipital lobes, related to the first stroke-like episode, and (F–J) in the right temporal occipital lobe, related to the second stroke-like episode. (K,L) Brain Magnetic Resonance Spectroscopy s... |
PMC9414032_F2_385433.jpg | What is the principal component of this image? | Biopsy specimen. (A) ragged red fibers (MGT staining); (B) COX-negative and SDH-positive fibers in blue (COX/SDH double staining) (bar = 20μm). |
PMC9414032_F2_385432.jpg | What is the main focus of this visual representation? | Biopsy specimen. (A) ragged red fibers (MGT staining); (B) COX-negative and SDH-positive fibers in blue (COX/SDH double staining) (bar = 20μm). |
PMC9414036_medicina-58-01027-f001_385454.jpg | What is the central feature of this picture? | A 66-year-old man was diagnosed with stage II pancreatic adenocarcinoma (T3N0M0). PET/CT scans performed at baseline reveal minor metabolic activity (yellow regions, (A,B); maximum standardized uptake value, 3.7) consistent with primary pancreatic mass; projection of maximal intensity PET imaging demonstrates 33 mL of ... |
PMC9414036_medicina-58-01027-f001_385453.jpg | What stands out most in this visual? | A 66-year-old man was diagnosed with stage II pancreatic adenocarcinoma (T3N0M0). PET/CT scans performed at baseline reveal minor metabolic activity (yellow regions, (A,B); maximum standardized uptake value, 3.7) consistent with primary pancreatic mass; projection of maximal intensity PET imaging demonstrates 33 mL of ... |
PMC9414036_medicina-58-01027-f001_385452.jpg | What is the focal point of this photograph? | A 66-year-old man was diagnosed with stage II pancreatic adenocarcinoma (T3N0M0). PET/CT scans performed at baseline reveal minor metabolic activity (yellow regions, (A,B); maximum standardized uptake value, 3.7) consistent with primary pancreatic mass; projection of maximal intensity PET imaging demonstrates 33 mL of ... |
PMC9414036_medicina-58-01027-f002_385449.jpg | What stands out most in this visual? | A 57-year-old man with pancreatic adenocarcinoma stage four. PET/CT scans performed at baseline reveal moderate metabolic activity (yellow regions, (A,B); maximum standardized uptake value, 6.6) consistent with primary pancreatic mass; projection of maximal intensity PET scan demonstrates 227 mL of tumor glycolytic act... |
PMC9414036_medicina-58-01027-f002_385450.jpg | Describe the main subject of this image. | A 57-year-old man with pancreatic adenocarcinoma stage four. PET/CT scans performed at baseline reveal moderate metabolic activity (yellow regions, (A,B); maximum standardized uptake value, 6.6) consistent with primary pancreatic mass; projection of maximal intensity PET scan demonstrates 227 mL of tumor glycolytic act... |
PMC9414036_medicina-58-01027-f002_385451.jpg | What can you see in this picture? | A 57-year-old man with pancreatic adenocarcinoma stage four. PET/CT scans performed at baseline reveal moderate metabolic activity (yellow regions, (A,B); maximum standardized uptake value, 6.6) consistent with primary pancreatic mass; projection of maximal intensity PET scan demonstrates 227 mL of tumor glycolytic act... |
PMC9414048_pathogens-11-00872-f002_385461.jpg | What is the core subject represented in this visual? | (A–G) Transmission electron micrographs of seven B. cereus- specific bacteriophages isolated in this study. (A) Ø1BC478; (B) Ø1BC3990; (C) Ø2BC4663; (D) Ø3BC4663; (E) Ø4BC4663(1); (F) Ø4BC4663(2); and (G) Ø1BC4663. The virions were negatively stained with uranyl acetate and visualized at a magnification of 100,000× (B,... |
PMC9414048_pathogens-11-00872-f002_385457.jpg | Can you identify the primary element in this image? | (A–G) Transmission electron micrographs of seven B. cereus- specific bacteriophages isolated in this study. (A) Ø1BC478; (B) Ø1BC3990; (C) Ø2BC4663; (D) Ø3BC4663; (E) Ø4BC4663(1); (F) Ø4BC4663(2); and (G) Ø1BC4663. The virions were negatively stained with uranyl acetate and visualized at a magnification of 100,000× (B,... |
PMC9414048_pathogens-11-00872-f002_385455.jpg | What's the most prominent thing you notice in this picture? | (A–G) Transmission electron micrographs of seven B. cereus- specific bacteriophages isolated in this study. (A) Ø1BC478; (B) Ø1BC3990; (C) Ø2BC4663; (D) Ø3BC4663; (E) Ø4BC4663(1); (F) Ø4BC4663(2); and (G) Ø1BC4663. The virions were negatively stained with uranyl acetate and visualized at a magnification of 100,000× (B,... |
PMC9414048_pathogens-11-00872-f002_385458.jpg | Describe the main subject of this image. | (A–G) Transmission electron micrographs of seven B. cereus- specific bacteriophages isolated in this study. (A) Ø1BC478; (B) Ø1BC3990; (C) Ø2BC4663; (D) Ø3BC4663; (E) Ø4BC4663(1); (F) Ø4BC4663(2); and (G) Ø1BC4663. The virions were negatively stained with uranyl acetate and visualized at a magnification of 100,000× (B,... |
PMC9414048_pathogens-11-00872-f002_385459.jpg | What object or scene is depicted here? | (A–G) Transmission electron micrographs of seven B. cereus- specific bacteriophages isolated in this study. (A) Ø1BC478; (B) Ø1BC3990; (C) Ø2BC4663; (D) Ø3BC4663; (E) Ø4BC4663(1); (F) Ø4BC4663(2); and (G) Ø1BC4663. The virions were negatively stained with uranyl acetate and visualized at a magnification of 100,000× (B,... |
PMC9414075_tropicalmed-07-00196-f002_385467.jpg | What is being portrayed in this visual content? | (A–F) cMRI illustrating LGE in a patient with subacute myopericarditis at the time of diagnosis (A–C) and 5 months post-diagnosis (D–F). cMRI, cardiac magnetic resonance imaging; LGE, late gadolinium enhancement. |
PMC9414075_tropicalmed-07-00196-f002_385463.jpg | What object or scene is depicted here? | (A–F) cMRI illustrating LGE in a patient with subacute myopericarditis at the time of diagnosis (A–C) and 5 months post-diagnosis (D–F). cMRI, cardiac magnetic resonance imaging; LGE, late gadolinium enhancement. |
PMC9414075_tropicalmed-07-00196-f002_385465.jpg | What is the dominant medical problem in this image? | (A–F) cMRI illustrating LGE in a patient with subacute myopericarditis at the time of diagnosis (A–C) and 5 months post-diagnosis (D–F). cMRI, cardiac magnetic resonance imaging; LGE, late gadolinium enhancement. |
PMC9414075_tropicalmed-07-00196-f002_385464.jpg | What is being portrayed in this visual content? | (A–F) cMRI illustrating LGE in a patient with subacute myopericarditis at the time of diagnosis (A–C) and 5 months post-diagnosis (D–F). cMRI, cardiac magnetic resonance imaging; LGE, late gadolinium enhancement. |
PMC9414089_viruses-14-01679-f002_385470.jpg | What is the principal component of this image? | Localization of TSWV-N and SBV-N relative to PB/SG in virus infected cells. (A) HsDCP1-mRFP construct was first transfected to the cells and followed by SBV infection. SBV N was detected by immunostaining. (B) 5d post TSWV infection, TSWV-N-GFP and AtRFP-DCP1 were agro-infiltrated to infected leaves, confocal microscop... |
PMC9414089_viruses-14-01679-f002_385468.jpg | What does this image primarily show? | Localization of TSWV-N and SBV-N relative to PB/SG in virus infected cells. (A) HsDCP1-mRFP construct was first transfected to the cells and followed by SBV infection. SBV N was detected by immunostaining. (B) 5d post TSWV infection, TSWV-N-GFP and AtRFP-DCP1 were agro-infiltrated to infected leaves, confocal microscop... |
PMC9414089_viruses-14-01679-f002_385476.jpg | What is the central feature of this picture? | Localization of TSWV-N and SBV-N relative to PB/SG in virus infected cells. (A) HsDCP1-mRFP construct was first transfected to the cells and followed by SBV infection. SBV N was detected by immunostaining. (B) 5d post TSWV infection, TSWV-N-GFP and AtRFP-DCP1 were agro-infiltrated to infected leaves, confocal microscop... |
PMC9414089_viruses-14-01679-f002_385474.jpg | What object or scene is depicted here? | Localization of TSWV-N and SBV-N relative to PB/SG in virus infected cells. (A) HsDCP1-mRFP construct was first transfected to the cells and followed by SBV infection. SBV N was detected by immunostaining. (B) 5d post TSWV infection, TSWV-N-GFP and AtRFP-DCP1 were agro-infiltrated to infected leaves, confocal microscop... |
PMC9414089_viruses-14-01679-f002_385475.jpg | What is shown in this image? | Localization of TSWV-N and SBV-N relative to PB/SG in virus infected cells. (A) HsDCP1-mRFP construct was first transfected to the cells and followed by SBV infection. SBV N was detected by immunostaining. (B) 5d post TSWV infection, TSWV-N-GFP and AtRFP-DCP1 were agro-infiltrated to infected leaves, confocal microscop... |
PMC9414089_viruses-14-01679-f002_385471.jpg | What is the core subject represented in this visual? | Localization of TSWV-N and SBV-N relative to PB/SG in virus infected cells. (A) HsDCP1-mRFP construct was first transfected to the cells and followed by SBV infection. SBV N was detected by immunostaining. (B) 5d post TSWV infection, TSWV-N-GFP and AtRFP-DCP1 were agro-infiltrated to infected leaves, confocal microscop... |
PMC9414089_viruses-14-01679-f002_385472.jpg | What key item or scene is captured in this photo? | Localization of TSWV-N and SBV-N relative to PB/SG in virus infected cells. (A) HsDCP1-mRFP construct was first transfected to the cells and followed by SBV infection. SBV N was detected by immunostaining. (B) 5d post TSWV infection, TSWV-N-GFP and AtRFP-DCP1 were agro-infiltrated to infected leaves, confocal microscop... |
PMC9414089_viruses-14-01679-f002_385473.jpg | What is the dominant medical problem in this image? | Localization of TSWV-N and SBV-N relative to PB/SG in virus infected cells. (A) HsDCP1-mRFP construct was first transfected to the cells and followed by SBV infection. SBV N was detected by immunostaining. (B) 5d post TSWV infection, TSWV-N-GFP and AtRFP-DCP1 were agro-infiltrated to infected leaves, confocal microscop... |
PMC9414089_viruses-14-01679-f002_385477.jpg | What is the principal component of this image? | Localization of TSWV-N and SBV-N relative to PB/SG in virus infected cells. (A) HsDCP1-mRFP construct was first transfected to the cells and followed by SBV infection. SBV N was detected by immunostaining. (B) 5d post TSWV infection, TSWV-N-GFP and AtRFP-DCP1 were agro-infiltrated to infected leaves, confocal microscop... |
PMC9414092_plants-11-02179-f002_385479.jpg | Describe the main subject of this image. | Fluorescence levels of 35S::HA3-FLAG3-ABI4-GFP seedling roots and embryosroots. The fluorescence of plants transformed with the 35S::HA3-FLAG3-ABI4-GFP construct was examined by microscopy. (A,B) Ten-day-old root; (C,D) embryo extracted from a seed imbibed for 24 h; (A,C) fluorescence images; (B,D) bright-field images.... |
PMC9414092_plants-11-02179-f002_385478.jpg | What is the main focus of this visual representation? | Fluorescence levels of 35S::HA3-FLAG3-ABI4-GFP seedling roots and embryosroots. The fluorescence of plants transformed with the 35S::HA3-FLAG3-ABI4-GFP construct was examined by microscopy. (A,B) Ten-day-old root; (C,D) embryo extracted from a seed imbibed for 24 h; (A,C) fluorescence images; (B,D) bright-field images.... |
PMC9414092_plants-11-02179-f002_385481.jpg | Can you identify the primary element in this image? | Fluorescence levels of 35S::HA3-FLAG3-ABI4-GFP seedling roots and embryosroots. The fluorescence of plants transformed with the 35S::HA3-FLAG3-ABI4-GFP construct was examined by microscopy. (A,B) Ten-day-old root; (C,D) embryo extracted from a seed imbibed for 24 h; (A,C) fluorescence images; (B,D) bright-field images.... |
PMC9414096_materials-15-05733-f003_385495.jpg | What is being portrayed in this visual content? | Electron micrographs and EDS maps showing the elemental distribution of Ti, Al, V and Fe in (A) the initial condition of TiAl6V4 wrought alloy and after different heat treatments, such as: (B) A 600, (C) STQ 900, (D) STA 900, (E) STQ 1100, (F,G) STA 1100 and (H) β 1100. |
PMC9414096_materials-15-05733-f003_385507.jpg | What key item or scene is captured in this photo? | Electron micrographs and EDS maps showing the elemental distribution of Ti, Al, V and Fe in (A) the initial condition of TiAl6V4 wrought alloy and after different heat treatments, such as: (B) A 600, (C) STQ 900, (D) STA 900, (E) STQ 1100, (F,G) STA 1100 and (H) β 1100. |
PMC9414096_materials-15-05733-f003_385508.jpg | What is the dominant medical problem in this image? | Electron micrographs and EDS maps showing the elemental distribution of Ti, Al, V and Fe in (A) the initial condition of TiAl6V4 wrought alloy and after different heat treatments, such as: (B) A 600, (C) STQ 900, (D) STA 900, (E) STQ 1100, (F,G) STA 1100 and (H) β 1100. |
PMC9414096_materials-15-05733-f003_385486.jpg | What can you see in this picture? | Electron micrographs and EDS maps showing the elemental distribution of Ti, Al, V and Fe in (A) the initial condition of TiAl6V4 wrought alloy and after different heat treatments, such as: (B) A 600, (C) STQ 900, (D) STA 900, (E) STQ 1100, (F,G) STA 1100 and (H) β 1100. |
PMC9414096_materials-15-05733-f003_385504.jpg | What is the principal component of this image? | Electron micrographs and EDS maps showing the elemental distribution of Ti, Al, V and Fe in (A) the initial condition of TiAl6V4 wrought alloy and after different heat treatments, such as: (B) A 600, (C) STQ 900, (D) STA 900, (E) STQ 1100, (F,G) STA 1100 and (H) β 1100. |
PMC9414096_materials-15-05733-f003_385499.jpg | What does this image primarily show? | Electron micrographs and EDS maps showing the elemental distribution of Ti, Al, V and Fe in (A) the initial condition of TiAl6V4 wrought alloy and after different heat treatments, such as: (B) A 600, (C) STQ 900, (D) STA 900, (E) STQ 1100, (F,G) STA 1100 and (H) β 1100. |
PMC9414096_materials-15-05733-f003_385491.jpg | What is the central feature of this picture? | Electron micrographs and EDS maps showing the elemental distribution of Ti, Al, V and Fe in (A) the initial condition of TiAl6V4 wrought alloy and after different heat treatments, such as: (B) A 600, (C) STQ 900, (D) STA 900, (E) STQ 1100, (F,G) STA 1100 and (H) β 1100. |
PMC9414096_materials-15-05733-f003_385494.jpg | What key item or scene is captured in this photo? | Electron micrographs and EDS maps showing the elemental distribution of Ti, Al, V and Fe in (A) the initial condition of TiAl6V4 wrought alloy and after different heat treatments, such as: (B) A 600, (C) STQ 900, (D) STA 900, (E) STQ 1100, (F,G) STA 1100 and (H) β 1100. |
PMC9414096_materials-15-05733-f003_385483.jpg | What is the focal point of this photograph? | Electron micrographs and EDS maps showing the elemental distribution of Ti, Al, V and Fe in (A) the initial condition of TiAl6V4 wrought alloy and after different heat treatments, such as: (B) A 600, (C) STQ 900, (D) STA 900, (E) STQ 1100, (F,G) STA 1100 and (H) β 1100. |
PMC9414096_materials-15-05733-f003_385488.jpg | What can you see in this picture? | Electron micrographs and EDS maps showing the elemental distribution of Ti, Al, V and Fe in (A) the initial condition of TiAl6V4 wrought alloy and after different heat treatments, such as: (B) A 600, (C) STQ 900, (D) STA 900, (E) STQ 1100, (F,G) STA 1100 and (H) β 1100. |
PMC9414096_materials-15-05733-f003_385493.jpg | What's the most prominent thing you notice in this picture? | Electron micrographs and EDS maps showing the elemental distribution of Ti, Al, V and Fe in (A) the initial condition of TiAl6V4 wrought alloy and after different heat treatments, such as: (B) A 600, (C) STQ 900, (D) STA 900, (E) STQ 1100, (F,G) STA 1100 and (H) β 1100. |
PMC9414096_materials-15-05733-f003_385487.jpg | What is the focal point of this photograph? | Electron micrographs and EDS maps showing the elemental distribution of Ti, Al, V and Fe in (A) the initial condition of TiAl6V4 wrought alloy and after different heat treatments, such as: (B) A 600, (C) STQ 900, (D) STA 900, (E) STQ 1100, (F,G) STA 1100 and (H) β 1100. |
PMC9414096_materials-15-05733-f003_385496.jpg | What is the central feature of this picture? | Electron micrographs and EDS maps showing the elemental distribution of Ti, Al, V and Fe in (A) the initial condition of TiAl6V4 wrought alloy and after different heat treatments, such as: (B) A 600, (C) STQ 900, (D) STA 900, (E) STQ 1100, (F,G) STA 1100 and (H) β 1100. |
PMC9414096_materials-15-05733-f003_385484.jpg | What is the dominant medical problem in this image? | Electron micrographs and EDS maps showing the elemental distribution of Ti, Al, V and Fe in (A) the initial condition of TiAl6V4 wrought alloy and after different heat treatments, such as: (B) A 600, (C) STQ 900, (D) STA 900, (E) STQ 1100, (F,G) STA 1100 and (H) β 1100. |
PMC9414096_materials-15-05733-f003_385506.jpg | What is shown in this image? | Electron micrographs and EDS maps showing the elemental distribution of Ti, Al, V and Fe in (A) the initial condition of TiAl6V4 wrought alloy and after different heat treatments, such as: (B) A 600, (C) STQ 900, (D) STA 900, (E) STQ 1100, (F,G) STA 1100 and (H) β 1100. |
PMC9414096_materials-15-05733-f003_385500.jpg | What's the most prominent thing you notice in this picture? | Electron micrographs and EDS maps showing the elemental distribution of Ti, Al, V and Fe in (A) the initial condition of TiAl6V4 wrought alloy and after different heat treatments, such as: (B) A 600, (C) STQ 900, (D) STA 900, (E) STQ 1100, (F,G) STA 1100 and (H) β 1100. |
PMC9414096_materials-15-05733-f003_385501.jpg | What is shown in this image? | Electron micrographs and EDS maps showing the elemental distribution of Ti, Al, V and Fe in (A) the initial condition of TiAl6V4 wrought alloy and after different heat treatments, such as: (B) A 600, (C) STQ 900, (D) STA 900, (E) STQ 1100, (F,G) STA 1100 and (H) β 1100. |
PMC9414096_materials-15-05733-f003_385502.jpg | Can you identify the primary element in this image? | Electron micrographs and EDS maps showing the elemental distribution of Ti, Al, V and Fe in (A) the initial condition of TiAl6V4 wrought alloy and after different heat treatments, such as: (B) A 600, (C) STQ 900, (D) STA 900, (E) STQ 1100, (F,G) STA 1100 and (H) β 1100. |
PMC9414096_materials-15-05733-f003_385482.jpg | Describe the main subject of this image. | Electron micrographs and EDS maps showing the elemental distribution of Ti, Al, V and Fe in (A) the initial condition of TiAl6V4 wrought alloy and after different heat treatments, such as: (B) A 600, (C) STQ 900, (D) STA 900, (E) STQ 1100, (F,G) STA 1100 and (H) β 1100. |
PMC9414096_materials-15-05733-f003_385490.jpg | What object or scene is depicted here? | Electron micrographs and EDS maps showing the elemental distribution of Ti, Al, V and Fe in (A) the initial condition of TiAl6V4 wrought alloy and after different heat treatments, such as: (B) A 600, (C) STQ 900, (D) STA 900, (E) STQ 1100, (F,G) STA 1100 and (H) β 1100. |
PMC9414113_Fig2_385509.jpg | What stands out most in this visual? | Pre-treatment examination: computed tomography. A, B The red arrows indicate the esophageal cancer lesions. C–E The red arrows indicate the swollen lymph nodes |
PMC9414113_Fig2_385511.jpg | What does this image primarily show? | Pre-treatment examination: computed tomography. A, B The red arrows indicate the esophageal cancer lesions. C–E The red arrows indicate the swollen lymph nodes |
PMC9414113_Fig2_385512.jpg | What is shown in this image? | Pre-treatment examination: computed tomography. A, B The red arrows indicate the esophageal cancer lesions. C–E The red arrows indicate the swollen lymph nodes |
PMC9414113_Fig2_385513.jpg | What key item or scene is captured in this photo? | Pre-treatment examination: computed tomography. A, B The red arrows indicate the esophageal cancer lesions. C–E The red arrows indicate the swollen lymph nodes |
PMC9414113_Fig2_385510.jpg | What is the focal point of this photograph? | Pre-treatment examination: computed tomography. A, B The red arrows indicate the esophageal cancer lesions. C–E The red arrows indicate the swollen lymph nodes |
PMC9414113_Fig3_385515.jpg | What does this image primarily show? | Pre-treatment examination: histopathological findings (A, B). The images were obtained after H&E staining under a magnification of respectively 50× and 200× |
PMC9414113_Fig5_385516.jpg | What is the core subject represented in this visual? | Post-treatment examination: gastroscopic findings (A, B), respectively middle esophagus and lower esophagus |
PMC9414113_Fig5_385517.jpg | What is the core subject represented in this visual? | Post-treatment examination: gastroscopic findings (A, B), respectively middle esophagus and lower esophagus |
PMC9414113_Fig6_385518.jpg | What is being portrayed in this visual content? | Post-treatment examination: computed tomography (A, B). The red arrows indicate the esophageal cancer lesions. C–E The red arrows indicate lymph nodes. All of them became smaller compared with pre-treatment |
PMC9414113_Fig6_385519.jpg | What is the main focus of this visual representation? | Post-treatment examination: computed tomography (A, B). The red arrows indicate the esophageal cancer lesions. C–E The red arrows indicate lymph nodes. All of them became smaller compared with pre-treatment |
PMC9414113_Fig6_385522.jpg | What's the most prominent thing you notice in this picture? | Post-treatment examination: computed tomography (A, B). The red arrows indicate the esophageal cancer lesions. C–E The red arrows indicate lymph nodes. All of them became smaller compared with pre-treatment |
PMC9414113_Fig6_385521.jpg | What is the main focus of this visual representation? | Post-treatment examination: computed tomography (A, B). The red arrows indicate the esophageal cancer lesions. C–E The red arrows indicate lymph nodes. All of them became smaller compared with pre-treatment |
PMC9414113_Fig7_385524.jpg | Describe the main subject of this image. | Post-treatment examination: postoperative histopathological findings (A, B). The images were obtained after H&E staining under a magnification of respectively 40× and 40×. The squamous epithelium is intact, and subepithelial proliferation of fibrous connective tissue with vasodilatation and inflammatory cell infiltrati... |
PMC9414113_Fig7_385523.jpg | What is the core subject represented in this visual? | Post-treatment examination: postoperative histopathological findings (A, B). The images were obtained after H&E staining under a magnification of respectively 40× and 40×. The squamous epithelium is intact, and subepithelial proliferation of fibrous connective tissue with vasodilatation and inflammatory cell infiltrati... |
PMC9414120_Fig1_385526.jpg | What object or scene is depicted here? | Ultrasound of the cardiac tumor. A Two-chamber view in transthoracic echocardiography shows a 23 mm × 8 mm mass which was polyp-like-shaped, homogeneous, firm, mobile and solitary centered on the lateral wall of the left ventricle. B Grey and C Color doppler flow imaging of four-chamber view in transesophageal echocard... |
PMC9414120_Fig1_385527.jpg | What is the focal point of this photograph? | Ultrasound of the cardiac tumor. A Two-chamber view in transthoracic echocardiography shows a 23 mm × 8 mm mass which was polyp-like-shaped, homogeneous, firm, mobile and solitary centered on the lateral wall of the left ventricle. B Grey and C Color doppler flow imaging of four-chamber view in transesophageal echocard... |
PMC9414120_Fig1_385528.jpg | Can you identify the primary element in this image? | Ultrasound of the cardiac tumor. A Two-chamber view in transthoracic echocardiography shows a 23 mm × 8 mm mass which was polyp-like-shaped, homogeneous, firm, mobile and solitary centered on the lateral wall of the left ventricle. B Grey and C Color doppler flow imaging of four-chamber view in transesophageal echocard... |
PMC9414137_Fig12_385534.jpg | What is the main focus of this visual representation? | Immunofluorescence staining of NF-κB. The expression of NF-κB in the nucleus was enhanced in the retina in the LD group. NF-κB was mainly expressed in the nucleus of the retina, which was amplified three times by the RGC layer. The expression decreased in the LC and HC groups |
PMC9414137_Fig12_385540.jpg | What does this image primarily show? | Immunofluorescence staining of NF-κB. The expression of NF-κB in the nucleus was enhanced in the retina in the LD group. NF-κB was mainly expressed in the nucleus of the retina, which was amplified three times by the RGC layer. The expression decreased in the LC and HC groups |
PMC9414137_Fig12_385536.jpg | What can you see in this picture? | Immunofluorescence staining of NF-κB. The expression of NF-κB in the nucleus was enhanced in the retina in the LD group. NF-κB was mainly expressed in the nucleus of the retina, which was amplified three times by the RGC layer. The expression decreased in the LC and HC groups |
PMC9414137_Fig12_385539.jpg | What is shown in this image? | Immunofluorescence staining of NF-κB. The expression of NF-κB in the nucleus was enhanced in the retina in the LD group. NF-κB was mainly expressed in the nucleus of the retina, which was amplified three times by the RGC layer. The expression decreased in the LC and HC groups |
PMC9414137_Fig12_385541.jpg | Can you identify the primary element in this image? | Immunofluorescence staining of NF-κB. The expression of NF-κB in the nucleus was enhanced in the retina in the LD group. NF-κB was mainly expressed in the nucleus of the retina, which was amplified three times by the RGC layer. The expression decreased in the LC and HC groups |
PMC9414137_Fig12_385529.jpg | Describe the main subject of this image. | Immunofluorescence staining of NF-κB. The expression of NF-κB in the nucleus was enhanced in the retina in the LD group. NF-κB was mainly expressed in the nucleus of the retina, which was amplified three times by the RGC layer. The expression decreased in the LC and HC groups |
PMC9414137_Fig12_385537.jpg | What is the core subject represented in this visual? | Immunofluorescence staining of NF-κB. The expression of NF-κB in the nucleus was enhanced in the retina in the LD group. NF-κB was mainly expressed in the nucleus of the retina, which was amplified three times by the RGC layer. The expression decreased in the LC and HC groups |
PMC9414137_Fig12_385535.jpg | What is the core subject represented in this visual? | Immunofluorescence staining of NF-κB. The expression of NF-κB in the nucleus was enhanced in the retina in the LD group. NF-κB was mainly expressed in the nucleus of the retina, which was amplified three times by the RGC layer. The expression decreased in the LC and HC groups |
PMC9414137_Fig12_385531.jpg | What is the dominant medical problem in this image? | Immunofluorescence staining of NF-κB. The expression of NF-κB in the nucleus was enhanced in the retina in the LD group. NF-κB was mainly expressed in the nucleus of the retina, which was amplified three times by the RGC layer. The expression decreased in the LC and HC groups |
PMC9414137_Fig12_385532.jpg | What is the main focus of this visual representation? | Immunofluorescence staining of NF-κB. The expression of NF-κB in the nucleus was enhanced in the retina in the LD group. NF-κB was mainly expressed in the nucleus of the retina, which was amplified three times by the RGC layer. The expression decreased in the LC and HC groups |
PMC9414137_Fig12_385542.jpg | What key item or scene is captured in this photo? | Immunofluorescence staining of NF-κB. The expression of NF-κB in the nucleus was enhanced in the retina in the LD group. NF-κB was mainly expressed in the nucleus of the retina, which was amplified three times by the RGC layer. The expression decreased in the LC and HC groups |
PMC9414160_FIG3_385545.jpg | What is the dominant medical problem in this image? | Bitewing radiograph showing the tooth 15 with mesial composite restoration approximating to pulp horn. |
PMC9414160_FIG3_385544.jpg | What is the dominant medical problem in this image? | Bitewing radiograph showing the tooth 15 with mesial composite restoration approximating to pulp horn. |
PMC9414160_FIG3_385543.jpg | What stands out most in this visual? | Bitewing radiograph showing the tooth 15 with mesial composite restoration approximating to pulp horn. |
PMC9414160_FIG9_385546.jpg | What is the core subject represented in this visual? | A: Clinical view for the implant insertion site. B: Radiographic view for the implant. |
PMC9414160_FIG9_385547.jpg | Describe the main subject of this image. | A: Clinical view for the implant insertion site. B: Radiographic view for the implant. |
PMC9414168_FIG1_385549.jpg | What is the principal component of this image? | Transthoracic echocardiogram with bubble study pre-procedure. Transthoracic echocardiogram with bubble study during the relaxation phase of the Valsalva maneuver. The microbubbles seen in the left ventricle signify a right-to-left shunt and thus a positive test.Beats per minute (BPM), Left atrium (LA), Left ventricle (... |
PMC9414168_FIG1_385550.jpg | What is being portrayed in this visual content? | Transthoracic echocardiogram with bubble study pre-procedure. Transthoracic echocardiogram with bubble study during the relaxation phase of the Valsalva maneuver. The microbubbles seen in the left ventricle signify a right-to-left shunt and thus a positive test.Beats per minute (BPM), Left atrium (LA), Left ventricle (... |
PMC9414168_FIG2_385551.jpg | What key item or scene is captured in this photo? | Transthoracic echocardiogram with bubble study post-procedure. Transthoracic echocardiogram and bubble study conducted after the closure procedure showing a negative bubble study and the occluder device in the correct location.Beats per minute (BPM), Left atrium (LA), Left ventricle (LV), Patent foramen ovale (PFO), Ri... |
PMC9414187_tomography-08-00174-f001_385553.jpg | What is shown in this image? | PET/CT ((a)—unenhanced CT; (b)—positron emission tomography; (c)—fusion imaging) showing a tumefactive alteration of the pancreatic body-tail (white arrows), with increased FDG accumulation (SUV = 4.4). |
PMC9414187_tomography-08-00174-f001_385552.jpg | What is the central feature of this picture? | PET/CT ((a)—unenhanced CT; (b)—positron emission tomography; (c)—fusion imaging) showing a tumefactive alteration of the pancreatic body-tail (white arrows), with increased FDG accumulation (SUV = 4.4). |
PMC9414187_tomography-08-00174-f001_385554.jpg | What is the core subject represented in this visual? | PET/CT ((a)—unenhanced CT; (b)—positron emission tomography; (c)—fusion imaging) showing a tumefactive alteration of the pancreatic body-tail (white arrows), with increased FDG accumulation (SUV = 4.4). |
PMC9414187_tomography-08-00174-f002_385556.jpg | What is the core subject represented in this visual? | MRI showing focal enlargement of pancreatic body (white arrows) iso-intense on T1w (a) and iso-hyper intense on T2w (b), with homogeneous enhancement after gadolinium-based contrast agent administration (c). |
PMC9414187_tomography-08-00174-f002_385557.jpg | What's the most prominent thing you notice in this picture? | MRI showing focal enlargement of pancreatic body (white arrows) iso-intense on T1w (a) and iso-hyper intense on T2w (b), with homogeneous enhancement after gadolinium-based contrast agent administration (c). |
PMC9414187_tomography-08-00174-f003_385559.jpg | What can you see in this picture? | MRCP showing focal main pancreatic duct caliber reduction at the level of the lesion with a slight dilatation above (white arrow). |
PMC9414187_tomography-08-00174-f005_385562.jpg | What's the most prominent thing you notice in this picture? | EUS features of the pancreatic lesion confirming the presence of a nodular area in the pancreas body (a); dominant blue color at elastography is an indicator of high tissue stiffness (b); poor contrast enhancement after i.v. administration of SonoVue (c); FNA with 22 G needle of the nodular area ((d); white arrow). |
PMC9414187_tomography-08-00174-f005_385560.jpg | What is the core subject represented in this visual? | EUS features of the pancreatic lesion confirming the presence of a nodular area in the pancreas body (a); dominant blue color at elastography is an indicator of high tissue stiffness (b); poor contrast enhancement after i.v. administration of SonoVue (c); FNA with 22 G needle of the nodular area ((d); white arrow). |
PMC9414187_tomography-08-00174-f006_385565.jpg | What is the principal component of this image? | Histopathological specimen ((a–d); hematoxylin eosin; 400× magnification): pancreatic exocrine tissue presented with marked atrophy, residual acini are distorted, and some inflammatory cells are identifiable. |
PMC9414187_tomography-08-00174-f006_385566.jpg | What is the focal point of this photograph? | Histopathological specimen ((a–d); hematoxylin eosin; 400× magnification): pancreatic exocrine tissue presented with marked atrophy, residual acini are distorted, and some inflammatory cells are identifiable. |
PMC9414187_tomography-08-00174-f007_385568.jpg | What is being portrayed in this visual content? | MRI follow-up 1 month after previous examination showing reduction in the previously described focal enlargement of pancreatic body (white arrows) isointense on T1w (a) and T2w (b), with homogeneous enhancement after gadolinium-based contrast agent administration (c) and no restricted water diffusion on DWI ((d); b val... |
PMC9414187_tomography-08-00174-f007_385567.jpg | What is the dominant medical problem in this image? | MRI follow-up 1 month after previous examination showing reduction in the previously described focal enlargement of pancreatic body (white arrows) isointense on T1w (a) and T2w (b), with homogeneous enhancement after gadolinium-based contrast agent administration (c) and no restricted water diffusion on DWI ((d); b val... |
PMC9414187_tomography-08-00174-f008_385573.jpg | What does this image primarily show? | PET/CT ((a)—unenhanced CT; (b)—positron emission tomography; (c)—fusion imaging) at 2 months follow-up confirmed radiological resolution as well as absence of pathologic FDG uptake (white arrows). |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.